Literature DB >> 18679651

[Methylation of the RASSF1A tumor suppressor gene promoter. Risk factor for carcinogenesis of urological tumors].

J Serth1, H Tezval, I Peters, F Atschekzei, K Rehmet, S Jurk, K Albrecht, M A Kuczyk, A S Merseburger.   

Abstract

Molecular targets of known risk factors for the development of urological tumors, such as age, smoking, and adiposity, have not yet been elucidated. Hypermethylation of CpG islands in promoters can lead to silencing of gene expression and has frequently been detected in tumors. Age-dependent accumulation of methylation of gene promoters has been observed in various normal tissues and is discussed as a common risk factor for carcinogenesis.Here we describe the RASSF1A tumor suppressor gene as exhibiting an age-dependent promoter methylation in normal kidney tissue, which is additionally affected by the risk factors of anthracosis and adiposity. Furthermore, we found significantly increased methylation of the RASSF1A promoter when comparing peripheral versus central zone prostatic tissue samples.Preliminary expression analysis indicates that RASSF1A could be involved in early tumorigenesis. Our results support the hypothesis that age and other lifestyle-dependent factors may influence promoter methylation of specific genes, possibly serving as future individual tumor risk markers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18679651     DOI: 10.1007/s00120-008-1821-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  10 in total

Review 1.  CpG island methylator phenotypes in aging and cancer.

Authors:  M Toyota; J P Issa
Journal:  Semin Cancer Biol       Date:  1999-10       Impact factor: 15.707

2.  The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.

Authors:  K Dreijerink; E Braga; I Kuzmin; L Geil; F M Duh; D Angeloni; B Zbar; M I Lerman; E J Stanbridge; J D Minna; A Protopopov; J Li; V Kashuba; G Klein; E R Zabarovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

3.  Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.

Authors:  Mark L Gonzalgo; Masashi Nakayama; Shing M Lee; Angelo M De Marzo; William G Nelson
Journal:  Urology       Date:  2004-02       Impact factor: 2.649

4.  Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples.

Authors:  Takayoshi Waki; Gen Tamura; Makoto Sato; Teiichi Motoyama
Journal:  Oncogene       Date:  2003-06-26       Impact factor: 9.867

5.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

6.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon.

Authors:  J P Issa; Y L Ottaviano; P Celano; S R Hamilton; N E Davidson; S B Baylin
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

7.  Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue.

Authors:  Inga Peters; Bernhard Vaske; Knut Albrecht; Markus A Kuczyk; Udo Jonas; Jürgen Serth
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254

8.  Age-related DNA methylation changes in normal human prostate tissues.

Authors:  Bernard Kwabi-Addo; Woonbok Chung; Lanlan Shen; Michael Ittmann; Thomas Wheeler; Jaroslav Jelinek; Jean-Pierre J Issa
Journal:  Clin Cancer Res       Date:  2007-07-01       Impact factor: 12.531

Review 9.  Role of the Ras-association domain family 1 tumor suppressor gene in human cancers.

Authors:  Angelo Agathanggelou; Wendy N Cooper; Farida Latif
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

10.  RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.

Authors:  Inga Peters; Kristina Rehmet; Nadine Wilke; Markus A Kuczyk; Jörg Hennenlotter; Tyark Eilers; Stefan Machtens; Udo Jonas; Jürgen Serth
Journal:  Mol Cancer       Date:  2007-07-16       Impact factor: 27.401

  10 in total
  2 in total

1.  [Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer].

Authors:  S Waalkes; H Eggers; J Rustemeier; G Wegener; F Jentzmik; M Schrader; R Hofmann; M A Kuczyk; A J Schrader
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

2.  Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis.

Authors:  Chun-Wen Su; Yu-Chao Chang; Ming-Hsien Chien; Yi-Hsien Hsieh; Mu-Kuan Chen; Chiao-Wen Lin; Shun-Fa Yang
Journal:  Cell Death Dis       Date:  2019-10-17       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.